Topics

Posted 9/12/2023, 7:56:31 PM

CDC Panel Backs COVID Vaccines for All Ages 6 Months and Up

New COVID-19 vaccines received backing from CDC panel on Tuesday.
Shots will be available across the U.S. later this week.
Advisers voted 13-1 to recommend vaccines for people 6 months and older.
Benefits of vaccination exceed risks for everyone.
Universal recommendation could improve access and equity.

npr.org

Relevant topic timeline:

8/17/2023

A winter of Covid optimism? It's possible, experts say.

Main Topic: Americans heading into the winter respiratory virus season with optimism despite an increase in Covid cases. Key Points: 1. Widespread immunity from Covid infection or vaccination, as well as updated booster shots, provides reassurance to public health officials. 2. Early indications from wastewater signal low Covid spread and no consistent data to suggest a surge. 3. Covid vaccines are holding steady against virus mutations, and updated shots are expected to be authorized soon. Traditional protection measures like staying home when sick and wearing masks remain effective.

8/18/2023

Fall COVID shots will boost protection against latest subvariants, Moderna says

Main topic: Moderna's updated COVID-19 vaccine shows efficacy against omicron subvariants. Key points: 1. Moderna's updated COVID-19 vaccine boosts neutralizing antibodies against omicron subvariants EG.5 and FL.1.5.1. 2. The booster shot is expected to be authorized and rolled out soon. 3. The preliminary trial data aims to reassure concerns about the vaccine's effectiveness against current variants.

8/25/2023

CDC expects new Covid vaccines from Pfizer, Moderna and Novavax to be available in mid-September

The Centers for Disease Control and Prevention (CDC) expects updated COVID-19 vaccines from Pfizer, Moderna, and Novavax to be available to the public in mid-September, providing a more specific timeline for the arrival of the shots, pending approvals from the FDA and CDC.

8/25/2023

CDC says there are no plans to bring back mask mandates, even as Covid cases rise

The United States is still weeks away from distributing Covid booster shots, despite a 21.6% increase in hospitalizations related to the virus, and the effectiveness of the boosters against new virus variants remains uncertain.

8/27/2023

Covid cases are rising, just as new vaccines are almost ready

The U.S. is experiencing a rise in Covid cases just as new vaccines that protect against the latest variants are almost ready.

9/6/2023

Moderna says updated COVID vaccine is effective against newer variant

Moderna's updated COVID-19 vaccine is likely to be effective against the highly-mutated BA.2.86 subvariant of the coronavirus, according to clinical trial data, providing reassurance for fall boosters and regulators.

9/11/2023

FDA Approves Updated COVID Boosters for Fall, Including for Babies 6 Months and Up

The FDA has approved updated COVID-19 vaccine and booster shots, targeting new variants, and making them available for Americans as young as 6 months old from Moderna and Pfizer.

9/13/2023

Updated COVID Boosters With Omicron Target Now Available, But Demand Uncertain

Americans can now receive an updated COVID-19 vaccine to reduce the severity of symptoms, protect against current variants, and curb the risk of "long COVID."

9/13/2023

COVID Booster Uptake Uncertain Despite New Shots; Addressing Safety Concerns Could Boost Vaccination Rates

Attitudes about COVID-19 vaccinations in the US are shifting, with survey results showing that about 43% of adults plan to get the latest COVID-19 vaccine, similar to the uptake of the annual flu shot, although concerns about vaccine safety still persist.

9/14/2023

New COVID booster with updated protection now available in some N.J. locations

New COVID-19 vaccines recommended by the CDC are now available in select locations in New Jersey and will be accessible statewide in the near future, providing updated protection against the virus for individuals aged 6 months and older.

10/3/2023

FDA authorizes updated Novavax COVID vaccine targeting new Omicron strains, adds alternative to Pfizer and Moderna shots

The FDA has authorized Novavax's updated Covid vaccine for emergency use in individuals aged 12 and older, providing an alternative to mRNA shots from Pfizer and Moderna.

Topics

Posted 9/12/2023, 7:56:31 PM

CDC Panel Backs COVID Vaccines for All Ages 6 Months and Up

New COVID-19 vaccines received backing from CDC panel on Tuesday.
Shots will be available across the U.S. later this week.
Advisers voted 13-1 to recommend vaccines for people 6 months and older.
Benefits of vaccination exceed risks for everyone.
Universal recommendation could improve access and equity.

npr.org

Relevant topic timeline:

8/17/2023

A winter of Covid optimism? It's possible, experts say.

8/18/2023

Fall COVID shots will boost protection against latest subvariants, Moderna says

8/25/2023

CDC expects new Covid vaccines from Pfizer, Moderna and Novavax to be available in mid-September

8/25/2023

CDC says there are no plans to bring back mask mandates, even as Covid cases rise

8/27/2023

Covid cases are rising, just as new vaccines are almost ready

The U.S. is experiencing a rise in Covid cases just as new vaccines that protect against the latest variants are almost ready.

9/6/2023

Moderna says updated COVID vaccine is effective against newer variant

9/11/2023

FDA Approves Updated COVID Boosters for Fall, Including for Babies 6 Months and Up

The FDA has approved updated COVID-19 vaccine and booster shots, targeting new variants, and making them available for Americans as young as 6 months old from Moderna and Pfizer.

9/13/2023

Updated COVID Boosters With Omicron Target Now Available, But Demand Uncertain

Americans can now receive an updated COVID-19 vaccine to reduce the severity of symptoms, protect against current variants, and curb the risk of "long COVID."

9/13/2023

COVID Booster Uptake Uncertain Despite New Shots; Addressing Safety Concerns Could Boost Vaccination Rates

9/14/2023

New COVID booster with updated protection now available in some N.J. locations

10/3/2023

FDA authorizes updated Novavax COVID vaccine targeting new Omicron strains, adds alternative to Pfizer and Moderna shots

The FDA has authorized Novavax's updated Covid vaccine for emergency use in individuals aged 12 and older, providing an alternative to mRNA shots from Pfizer and Moderna.